NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Intellia Therapeutics, Inc. ("Intellia" or "the Company") (NASDAQ:NTLA). Investors who purchased Intellia securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NTLA. […]

NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Luna Innovations Incorporated ("Luna" or "the Company") (NASDAQ:LUNA). Investors who purchased Luna securities prior to May 16, 2022, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zeta Global Holdings Corp. ("Zeta" or "the Company") (NYSE:ZETA). Investors who purchased Zeta securities prior to February 27, 2024, and continue to hold to the present, are encouraged to

NEW YORK, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of JinkoSolar Holding Co., Ltd. ("JinkoSolar" or "the Company") (NYSE:JKS). Investors who purchased JinkoSolar securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/JKS.

NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, Inc. ("Enfusion") (NYSE:ENFN) and Clearwater Analytics. Investors who purchased Enfusion and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:

NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arbor Realty Trust ("Arbor Realty" or "the Company") (NYSE:ABR). Investors who purchased Arbor Realty securities prior to May 7, 2021, and continue to hold to the present, are encouraged

NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Allarity Therapeutics, Inc. ("Allarity" or "the Company") (NASDAQ:ALLR). Investors who purchased Allarity securities prior to May 17, 2022, and continue to hold to the present, are encouraged to obtain

LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against Kyverna Therapeutics, Inc. ("Kyverna" or "the Company") (NASDAQ:KYTX) for violations of the federal securities laws. Investors who purchased the Company’s securities pursuant and/or traceable

LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of e.l.f. Beauty, Inc. ("e.l.f. Beauty" or "the Company") (NYSE:ELF) for violations of the securities laws. The investigation focuses on whether the Company issued

NEW YORK, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Edison International ("Edison" or "the Company") (NYSE:EIX). Investors who purchased Edison securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/EIX. Investigation Details